Puritan Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
as on 27-06-2024
- Paid Up Capital ₹ 1.12 M
as on 27-06-2024
- Company Age 24 Year, 1 Month
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 1.42 Cr
as on 27-06-2024
- Revenue -1.37%
(FY 2019)
- Profit -97.69%
(FY 2019)
- Ebitda -101.99%
(FY 2019)
- Net Worth -9.26%
(FY 2019)
- Total Assets -1.72%
(FY 2019)
About Puritan Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 1.12 M.
The company currently has active open charges totaling ₹1.42 Cr.
Shivani Modan, Sheela Sinha, Chandra Sharma, and One other member serve as directors at the Company.
- CIN/LLPIN
U00304BR2000PTC009452
- Company No.
009452
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2000
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Puritan Pharmaceutical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhinav Bhushan  | Managing Director | 20-Nov-2000 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shivani Modan | Director | 28-May-2004 | Current |
| Sheela Sinha | Director | 20-Nov-2000 | Current |
| Chandra Sharma | Director | 20-Nov-2000 | Current |
Financial Performance of Puritan Pharmaceutical.
Puritan Pharmaceutical Private Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 1.37% decrease. The company also saw a substantial fall in profitability, with a 97.69% decrease in profit. The company's net worth dipped by a decrease of 9.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Puritan Pharmaceutical?
In 2019, Puritan Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 27 Feb 2015 | ₹1.20 M | Open |
Punjab National Bank Creation Date: 14 Sep 2004 | ₹0.50 M | Open |
State Bank Of Mysore Creation Date: 18 Jan 1995 | ₹1.25 Cr | Open |
How Many Employees Work at Puritan Pharmaceutical?
Unlock and access historical data on people associated with Puritan Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Puritan Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Puritan Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
